logo
Prolactin – to be reconsidered in canine mammary tumourigenesis?
Diagnostic accuracy of pre-treatment biopsy for grading soft tissue sarcomas in dogs
Development of a limited-sampling model for prediction of doxorubicin exposure in dogs
redox status evaluation in dogs affected by mast cell tumour
Lack of association between p53 SNP and FISS in a cat population from Germany
Sensitive detection of the c-KIT c .1430G>T mutation by mutant-specific polymerase chain reaction in feline mast cell tumours
Serum neopterin levels in female dogs with malignant mammary tumours
The growth of the canine glioblastoma cell line D-GBM and the canine histiocytic sarcoma cell line DH82 is inhibited by the resveratrol oligomers hopeaphenol and r2-viniferin
Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer